Alexander Ruckdaeschel
Glimpse GroupAbout Alexander Ruckdaeschel
Alexander Ruckdaeschel, 53, is an independent director of The Glimpse Group (VRAR) and has served on the Board since July 2021. He brings over 20 years of financial industry experience across the U.S. and Europe as a co-founder, partner and senior executive, including prior service on the board of Vuzix Corporation (Nasdaq: VUZI) where he chaired the compensation committee; his background includes startup fund management and prior service in the German military and as a research assistant at Dunmore Management . He is affirmed independent under Nasdaq standards and serves as Chair of Glimpse’s Compensation Committee, and as a member of the Nominating & Corporate Governance and Strategy Committees .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Vuzix Corporation (Nasdaq: VUZI) | Director; Compensation Committee Chair | 2012 – June 2021 | Chaired compensation committee (oversight of exec pay and equity plans) |
| Herakles Capital Management | Co-founder | 2008 (co-founded) | Investment leadership; startup experience noted |
| AMK Capital Advisors | Co-founder | 2008 (co-founded) | Investment leadership; startup experience noted |
External Roles
- The proxy notes he “sits on several boards,” but does not list current public company boards beyond VRAR .
Board Governance
| Item | Detail |
|---|---|
| Independence | Board affirmed Ruckdaeschel is independent; all members of Audit, Nominating & Corporate Governance, and Compensation Committees are independent . |
| Board Meetings (FY2025) | Board held 5 meetings; no director attended fewer than 75% of aggregate Board and committee meetings . |
| Annual Meeting Attendance | He did not attend the 2024 annual meeting (all directors except Tamar Elkeles and Alexander Ruckdaeschel attended) . |
| Board Leadership | CEO also serves as Board Chair; no lead independent director . |
Committee Assignments (FY2025)
| Committee | Role | Meetings Held |
|---|---|---|
| Compensation Committee | Chair; member | 3 |
| Nominating & Corporate Governance Committee | Member | 1 |
| Strategy Committee | Member | 9 |
Fixed Compensation
| Component | Amount/Policy |
|---|---|
| Annual retainer (cash) | $0 – Directors receive no cash compensation other than expense reimbursement . |
| Committee membership fees | $0 . |
| Committee chair fees | $0 . |
| Meeting fees | $0 . |
Performance Compensation
| Equity Component | FY2025 Detail |
|---|---|
| Option Awards (grant date fair value) | $81,788 . |
| Equity type | Stock options (granted under the Equity Incentive Plan) . |
| Options held (6/30/2025) | 37,500 options to purchase common stock . |
| Vested vs. near-term vesting | 28,125 fully vested options; 6,250 options vesting within 60 days of record date . |
Note: The proxy does not disclose strike prices, expiration dates or vesting schedules for director options; details are limited to grant-date fair value and aggregate options held .
Other Directorships & Interlocks
| Company | Role | Status | Interlock/Conflict Notes |
|---|---|---|---|
| Vuzix Corporation (Nasdaq: VUZI) | Director; Compensation Committee Chair | Prior (2012–June 2021) | Prior role in AR smart glasses; no current interlock disclosed with VRAR . |
Expertise & Qualifications
- Compensation governance: Chaired Vuzix Compensation Committee; chairs Glimpse Compensation Committee, indicating pay governance expertise .
- Financial and investment experience: Co-founded Herakles Capital Management and AMK Capital Advisors; partner roles at Alpha Plus Advisors and Nanostart AG (headed U.S. group) .
- Startup and fund management: Managed DAC Nanotech-Fund and Biotech-Fund, indicating early-stage operational oversight .
Equity Ownership
| Metric | Amount |
|---|---|
| Total beneficial ownership (shares) | 83,264 . |
| Ownership % of outstanding | 0.39% (based on 21,076,506 shares outstanding at record date) . |
| Common shares owned | 48,889 . |
| Options – fully vested | 28,125 . |
| Options – vesting within 60 days | 6,250 . |
| Hedging | “Employee, officer and director hedging: None” (proxy disclosure) . |
| Related-party transactions | None disclosed . |
Insider Trades
| Filing Date | Transaction Date | Type | Security | Shares | Price | Post-transaction Securities Owned | Source |
|---|---|---|---|---|---|---|---|
| 2024-03-05 | 2024-03-01 | Award (A) | Common Stock | 25,000 | $0.00 | 48,889 | |
| 2024-03-05 | 2024-02-29 | Return to issuer (D) | Stock Option (Right to Purchase) | 37,778 | $0.00 | 0 (for the option security) |
Governance Assessment
- Alignment: No cash fees and equity-only compensation suggest alignment with long-term shareholder value; his meaningful beneficial ownership (0.39%) further supports “skin in the game” .
- Pay governance: As Compensation Committee Chair with prior compensation chair experience at Vuzix, he is positioned to oversee pay-for-performance and equity plan integrity; the committee met three times in FY2025 .
- Engagement risk: Non-attendance at the 2024 annual meeting is a minor red flag for shareholder engagement; Board policy expects attendance absent compelling circumstances .
- Conflicts: No related-party transactions disclosed; Board affirms independence; no hedging disclosed; no pledging disclosed in the proxy .
- Broader board structure: Combined CEO/Chair and no lead independent director heighten the importance of strong independent committee chairs (including Ruckdaeschel) to ensure effective oversight .
- Say-on-Pay context: FY2024 say-on-pay passed (For: 11,474,458; Against: 2,118,044; Abstain: 344,124), indicating shareholder support for compensation practices overseen by the Compensation Committee .